Form 4 for MYO MYOMO, INC.
Accepted 2025-01-24 00:00:00 ET · period of report 2024-06-09 · accession 0000950170-25-008872 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-01-24 | 2024-06-09 | MYO | Kovelman Harry | Chief Medical Off | M - OptEx | $0.00 | +1,235 | 124.5K | +1% | $0 |
| D | 2025-01-24 | 2024-06-09 | MYO | Kovelman Harry | Chief Medical Off | M - OptEx | $0.00 | -1,235 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-06-09 | M | A | 1,235 | $0.00 | 124,549 | D | — | — | (F1) Represents vesting of performance-based restricted stock units granted under the Issuer's 2018 Stock Option and Incentive plan based on the relative stock price performance of the Company's common stock compared to a peer group of companies as measured from June 10, 2021 to March 9, 2024. |
| 2 | Derivative | Restricted Stock Units | 2024-06-09 | M | D | 1,235 | $0.00 | 0 | D | $0.00 · 2024-06-09 to 2024-06-09 | 1,235 Common Stock |